Home/Filings/4/0001415889-24-007846
4//SEC Filing

THEUER CHARLES 4

Accession 0001415889-24-007846

CIK 0001394319other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 5:56 PM ET

Size

9.0 KB

Accession

0001415889-24-007846

Insider Transaction Report

Form 4
Period: 2024-03-12
THEUER CHARLES
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2023-04-20$0.14/sh+3,500$482402,917 total
  • Award

    Common Stock

    2023-10-20$0.13/sh+3,500$467406,417 total
  • Award

    Employee Stock Option (Right to Buy)

    2024-03-12+518,300518,300 total
    Exercise: $0.39Exp: 2034-03-11Common Stock (518,300 underlying)
Footnotes (3)
  • [F1]Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023.
  • [F2]Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2023.
  • [F3]1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.

Issuer

Tracon Pharmaceuticals, Inc.

CIK 0001394319

Entity typeother

Related Parties

1
  • filerCIK 0001631338

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:56 PM ET
Size
9.0 KB